Ensuring American Pharmaceutical Supply Chain Resilience by Filling the Strategic Active Pharmaceutical Ingredients Reserve
President Donald Trump signed it on August 13, 2025. Published in the Federal Register on August 19, 2025, 90 FR 40223.
What this order does
Not startedPlain-language account: Not started.
On the record
On the record: Not started.
Press releases by members of Congress
From a secondary sourceThese are press releases from members' official websites that name this order. We save a copy of each one.
1 press release
-
“WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) today celebrated the Executive Order (EO) signed by President Trump entitled “Ensuring American Pharmaceutical Supply Chain Resilience by Filling the Strategic Active Pharmaceutical Ingredients Reserve,” which advances key priorities for the American-Made Medicines Caucus.”
Read from 539 of 539 members' sites, releases since January 3, 2025, through October 7, 2026.
Press releases by organizations
No saved press release from these organizations names this order.
Read from 510 of 510 organizations' sites, releases since January 3, 2025, through October 7, 2026.
Agencies the Federal Register lists for this order
Where this comes from
We saved our own copy of the Federal Register's file for this order before writing this page. A code beside a file is its fingerprint, a short code that changes if the file's contents change.
The Federal Register's note on this order:
- See: EO 13944, August 6, 2020